Emtora Biosciences
PrivateLast Round
Grant
May 22, 2025
Total Funding Raised
$32.17M
Company Overview
Emtora Biosciences operates in Healthcare & Life Sciences and is based in San Antonio, Texas. Its latest recorded funding round was a Grant round in May 2025.
Emtora Biosciences is a clinical-stage biopharmaceutical company that develops eRapa, a proprietary micro-encapsulated formulation of rapamycin for the treatment of cancer and rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emtora Biosciences Comparables
Compare Emtora Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tornado Therapeutics | 77% | |
| Recursion Pharmaceuticals | 77% | |
| S.L.A. Pharma AG | 75% |
For institutional investors. Book with your work email.
Emtora Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 22, 2025 | ||||
| Grant | Aug 17, 2022 | ||||
| Grant | Apr 1, 2020 | ||||
| Grant | Aug 21, 2019 | ||||
| Convertible Debt | Feb 28, 2019 | ||||
Series A | Jun 2, 2015 |
For institutional investors. Book with your work email.
Emtora Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2025
$3M grant received from CPRIT
- Apr 1, 2020
Secured $2.8M from the National Cancer Institute.
For institutional investors. Book with your work email.
Emtora Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Emtora Biosciences's valuation, stock price, and market status.
Is Emtora Biosciences a public or private company?
Emtora Biosciences is a private company.
What is the current stock price of Emtora Biosciences?
Emtora Biosciences is a private company, so its shares have no public market price. Caplight tracks Emtora Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emtora Biosciences worth (valuation)?
Valuation information for Emtora Biosciences is not publicly available.
Can I buy Emtora Biosciences stock?
Emtora Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emtora Biosciences's last funding round?
Emtora Biosciences's most recent funding round was Grant on May 22, 2025.
Who are the main investors in Emtora Biosciences?
Key investors in Emtora Biosciences include National Cancer Institute, Cancer Prevention and Research Institute of Texas (CPRIT).
Will Emtora Biosciences IPO soon?
No public IPO plans have been announced for Emtora Biosciences.
How can I track Emtora Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Emtora Biosciences's shares on secondary markets.